Investing First patient dosed in Phase IIb imaging for Brain Mets by April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post S&P 500 Rises from Bearish to Neutral, But Will It Last? You may also like Crypto Market Update: Bitcoin Price Takes Hit Heading... October 14, 2025 Altech Batteries Ltd$6M Placement to Advance Battery Projects October 14, 2025 Crypto Market Update: Sector Rebounds After US$20 Billion... October 14, 2025 Forte Minerals Appoints Patrick Evans as Non-Executive Chairman... October 14, 2025 Cespira Signs Agreement to Supply Components for a... October 14, 2025 Locksley Resources LimitedQualifies for Trading on U.S. OTCQX... October 13, 2025 Successful Completion-Impurity Removal Neutralization Tests October 13, 2025 Locksley Qualifies for Trading on U.S. OTCQX Market October 13, 2025 Successful A$4.5m Two Tranche Placement October 13, 2025 Tech Weekly: Market Dives After Week-Long Rally as... October 11, 2025